ASN: Caffeine Associated With Reduced Mortality in CKD

This article originally appeared here.
Share this content:
ASN: Caffeine Associated With Reduced Mortality in CKD
ASN: Caffeine Associated With Reduced Mortality in CKD

FRIDAY, Nov. 3, 2017 (HealthDay News) -- Caffeine consumption appears to have a dose-dependent protective effect against mortality in chronic kidney disease (CKD) patients, according to a study presented at the annual meeting of the American Society of Nephrology, being held Oct. 31 to Nov. 5 in New Orleans.

Miguel Bigotte Vieira, M.D., from the Centro Hospitalar Lisboa Norte in Portugal, and colleagues examined the association between caffeine consumption and mortality among 2,328 patients with CKD in a prospective cohort study using data from the National Health and Nutrition Examination Survey (1999 to 2010).

The researchers found a dose-dependent inverse association between caffeine and all-cause mortality. Compared with individuals in the first quartile of caffeine consumption, those in the second, third, and fourth quartiles had adjusted hazard ratios for mortality of 0.88 (95 percent confidence, 0.68 to 1.44), 0.78 (95 percent confidence, 0.6 to 1.01), and 0.76 (95 percent confidence, 0.59 to 0.97), respectively (P = 0.027 for trend across quartiles). This association was independent of confounding variables including age, gender, race, annual family income, education level, estimated glomerular filtration rate, albumin/creatinine ratio, hypertension, smoking status, dyslipidemia, body mass index, previous cardiovascular events, and diet.

"These results suggest that advising patients with CKD to drink more caffeine may reduce their mortality," Vieira said in a statement. "This would represent a simple, clinically beneficial, and inexpensive option, though this benefit should ideally be confirmed in a randomized clinical trial."

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Enrollment Under the Affordable Care Act Down From Last Year

Enrollment Under the Affordable Care Act Down From ...

In most states, Saturday is the sign-up deadline for coverage beginning Jan. 1

Recalled Kotex Tampons Can Unravel Inside Body

Recalled Kotex Tampons Can Unravel Inside Body

Small number of reports include infections, vaginal irritation, localized vaginal injury

FDA: Some E-Cigarette Liquids Contain Erectile Dysfunction Meds

FDA: Some E-Cigarette Liquids Contain Erectile Dysfunction Meds

Sildenafil and tadalafil not approved to be sold over the counter and are being sold illegally

is free, fast, and customized just for you!




Already a member?

Sign In Now »